<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00399815</url>
  </required_header>
  <id_info>
    <org_study_id>ELASTO2</org_study_id>
    <nct_id>NCT00399815</nct_id>
  </id_info>
  <brief_title>Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic viral hepatitis C is a frequent liver disease. It is associated with variable degree
      of hepatic fibrosis. To date, liver histology is still regarded as the gold standard to
      detect, diagnose and quantify liver fibrosis. This requires to perform a liver biopsy. Severe
      complications are associated to this procedure in 0.01 to 0.1% of cases. Because of this, the
      repetition of the biopsy to evaluate the progression of the disease or the response to
      treatment poses ethical questions. Also, liver biopsy only explore a minimal portion of the
      liver and liver fibrosis, which is not homogeneous, may be under- or over-estimated.

      To avoid risks linked to invasive technique and sampling errors associated to liver biopsy,
      efforts are being made to develop non-invasive technology to detect and quantitate liver
      fibrosis.

      In this study we will perform in patients with chronic hepatitis C, serum tests, fibroscan
      (elastography of liver parenchyma determined by ultra-sounds), and elastography of liver
      parenchyma by MRI.

      This study will allow

        -  to determine whether non-invasive tests effectively measure liver fibrosis

        -  to compare each non-invase test with results of liver biopsy

        -  to determine whether a non-invasive test or a combination of non invasive tests may be
           used to accurately evaluate liver fibrosis in patients with chronic hepatitis C.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <completion_date type="Anticipated">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hepatitis C, Chronic</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      liver biopsy serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic hepatitis C
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  alteration of liver function tests (ALT, AST)

          -  HCV RNA positive

        Exclusion Criteria:

          -  clotting disorder

          -  ongoing treatment with anti-coagulant or anti-aggregant

          -  advanced or decompensated cirrhosis (Child-Pugh class C)

          -  hepatocellular carcinoma

          -  other cancer

          -  history of surgery for brain aneurysm

          -  pace maker or defibrillator

          -  ocular metal foreign body
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves J Horsmans, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Cliniques Universitaires StLuc, Université catholique de Louvain (UCL), Brussels, Belgium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yves J Horsmans, M.D., Ph.D.</last_name>
    <phone>32 2 764 28 37</phone>
    <email>horsmans@gaen.ucl.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bernard VanBeers, M.D.,</last_name>
    <phone>32 2 764 29 45</phone>
    <email>vanbeers@rdgn.ucl.ac.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cliniques Universitaires StLuc, Université catholique de Louvain (UCL)</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2006</study_first_submitted>
  <study_first_submitted_qc>November 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2006</study_first_posted>
  <last_update_submitted>September 17, 2009</last_update_submitted>
  <last_update_submitted_qc>September 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof Yves Horsmans</name_title>
    <organization>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</organization>
  </responsible_party>
  <keyword>Chronic viral hepatitis C</keyword>
  <keyword>HCV RNA</keyword>
  <keyword>Fibroscan</keyword>
  <keyword>Fibrotest</keyword>
  <keyword>hepatic elastography by MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

